Est. 2001·3,000+ placements · six offices · four regions

Traffio

US Sales Lead - first full-time hire in the United States, spearheading US market entry

Traffio Traffio is an Australian SaaS company providing a full-stack ERP and workforce-management platform for the traffic control and roadworks industry, covering crew scheduling, payroll, equipment tracking, compliance and invoicing.

US Sales Lead - first full-time hire in the United States, spearheading US market entryUnited States (Dallas / Fort Worth)SaaS / Workforce Management

The market for this leadership

Live MitchelLake intelligence across SaaS / Workforce Management and Americas.

Adjacent signals across SaaS / Workforce Management

Layoffs · Americas

Chime

Chime announced a 10% workforce reduction driven by AI-powered operational efficiencies.

Product Launch · Americas

Louis Dreyfus Company

Louis Dreyfus Company opened its first dedicated pea protein isolate facility in Yorkton, Saskatchewan. At full capacity, the plant will process 75,000 metric tonnes of yellow peas annually into protein isolate, fibre, and starch. This represents a strategic diversification from commodity trading toward higher-value processed ingredients, leveraging proprietary technology and North American supply chain positioning.

Ma Activity · Americas

Saipem

Saipem and Subsea7 merger cleared for completion in the US, indicating final regulatory approval achieved.

Product Launch · Americas

Zoox

Zoox (Amazon-owned autonomous vehicle company) received NHTSA clearance to deploy steering-wheel-free robotaxis in Los Angeles and San Francisco, with approval to begin charging for rides subject to state and local approvals.

Capital Raising · Americas

Equinix

Equinix is raising $3B through a US investment-grade bond sale to fund its strategic pivot toward AI infrastructure and strengthen competitive positioning in the data center market.

Ma Activity · Americas

Hippocratic AI

Hippocratic AI acquired Grove AI, a startup formed in 2024 that uses voice agents to recruit eligible patients for clinical trials. The acquisition occurred in 2026, approximately 2 years after Grove AI's founding.

Nearby in the record